Catalyst Wire Dossier Catalyst Wire Dossier

CD123 Redirected Autologous T Cells

CD123 CAR-T cells · University of Pennsylvania
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD123 Redirected Autologous T Cells, covering 2017-10-17 to 2017-10-17. Get the full timeline:

Most recent: Clinical Trial Update: CD123 Redirected Autologous T Cells for AML [EARLY_Phase 1]

See pricing